Cargando…

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

Chronic hepatitis B virus (HBV) infection is a global health problem that presents as a spectrum of liver disease, reflecting an interplay between the virus and the host immune system. HBV genomes exist as episomal covalently closed circular DNA (cccDNA) or chromosomal integrants. The relative contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magri, Andrea, Harris, James M., D’Arienzo, Valentina, Minisini, Rosalba, Jühling, Frank, Wing, Peter A. C., Rapetti, Rachele, Leutner, Monica, Testoni, Barbara, Baumert, Thomas F., Zoulim, Fabien, Balfe, Peter, Pirisi, Mario, McKeating, Jane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146050/ https://www.ncbi.nlm.nih.gov/pubmed/35632812 http://dx.doi.org/10.3390/v14051070

Ejemplares similares

Gene Editing Technologies to Target HBV cccDNA
por: Martinez, Maria Guadalupe, et al.
Publicado: (2022)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
por: Wing, Peter AC, et al.
Publicado: (2019)

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients
por: Wang, Yang, et al.
Publicado: (2022)

Estimating hepatitis B virus cccDNA persistence in chronic infection(†)
por: Lythgoe, Katrina A, et al.
Publicado: (2020)

Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs
por: Li, Feng, et al.
Publicado: (2016)

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target
por: Verrier, Eloi R, et al.
Publicado: (2023)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Hepatitis B Viral DNA Decline at Loss of HBeAg Is Mainly Explained by Reduced cccDNA Load – Down-Regulated Transcription of PgRNA Has Limited Impact
por: Malmström, Sebastian, et al.
Publicado: (2012)

The Role of cccDNA in HBV Maintenance
por: Allweiss, Lena, et al.
Publicado: (2017)

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023)

Mapping the Interactions of HBV cccDNA with Host Factors
por: Mohd-Ismail, Nur K., et al.
Publicado: (2019)

Mechanism of Hepatitis B Virus cccDNA Formation
por: Wei, Lei, et al.
Publicado: (2021)

HBV cccDNA and Its Potential as a Therapeutic Target
por: Zhu, Anjing, et al.
Publicado: (2019)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
por: Lim, Chee Kent, et al.
Publicado: (2006)

Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018)

Circadian control of hepatitis B virus replication
por: Zhuang, Xiaodong, et al.
Publicado: (2021)

Is the function of the HBeAg really unknown?
por: Milich, David R.
Publicado: (2019)

Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter
por: Wing, Peter A.C., et al.
Publicado: (2021)

IFN-α confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA
por: Yuan, Ying, et al.
Publicado: (2020)

Dynamics of HBV cccDNA expression and transcription in different cell growth phase
por: Chong, Chin-Liew, et al.
Publicado: (2011)

Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
por: Seeger, Christoph, et al.
Publicado: (2016)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus
por: Kitamura, Kouichi, et al.
Publicado: (2018)

cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication
por: Dandri, Maura, et al.
Publicado: (2020)

Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B
por: Winther, Thilde Nordmann, et al.
Publicado: (2013)

A PCR assay to quantify patterns of HBV transcription
por: D’Arienzo, Valentina, et al.
Publicado: (2019)

Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver
por: Bae, Sung Kwan, et al.
Publicado: (2012)

Manifestations of Perihepatic Lymph Nodes in Acute Flare of Chronic Hepatitis B: Association with HBeAg Status and with HBeAg Seroconversion
por: Ko, Yen-Ling, et al.
Publicado: (2015)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
por: Song, Guangjun, et al.
Publicado: (2023)

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
por: García-López, Mireia, et al.
Publicado: (2021)

Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
por: Liu, Fei, et al.
Publicado: (2013)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome
por: Yang, Guang, et al.
Publicado: (2019)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
por: Doan, Phuong Thi Bich, et al.
Publicado: (2023)

The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore
por: Lacey, L F, et al.
Publicado: (2007)

Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro
por: Tacke, Frank, et al.
Publicado: (2012)

HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients
por: Yang, Jiezuan, et al.
Publicado: (2014)

Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China
por: Chen, Tianyan, et al.
Publicado: (2018)

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome
por: Palumbo, Gianna Aurora, et al.
Publicado: (2015)

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5r8qeui8tl8dtmn99l99p3pq3f